Clinical Trial Update: Erlotinib in Treating Patients With Recurrent Malignant Glioma or Recurrent or Progressive Meningioma [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating erlotinib in adults with recurrent malignant glioma or recurrent/progressive meningioma; the study is completed with results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Astrocytoma
• Anaplastic Oligodendroglioma
• Giant Cell Glioblastoma
• Glioblastoma
• Gliosarcoma
• Meningioma

Drugs mentioned

• ERLOTINIB (Erlotinib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Adult Anaplastic Astrocytoma, Adult Anaplastic Oligodendroglioma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2017-07-13